At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
INNV InnovAge Holding Corp.
Post-Market Trading 01-02 19:57:16 EST
3.94
+0.01
+0.25%
盘后3.94
+0.000.00%
16:20 EST
High4.37
Low3.85
Vol64.34K
Open3.91
D1 Closing3.93
Amplitude13.26%
Mkt Cap533.69M
Tradable Cap84.78M
Total Shares135.46M
T/O261.55K
T/O Rate0.30%
Tradable Shares21.52M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
JPMorgan Downgrades InnovAge to Underweight From Neutral, Adjusts Price Target to $5 From $6
Headquartered in San Diego, Innovus Pharma is an emerging over-the-counter ("OTC") consumer goods and specialty pharmaceutical company engaged in the commercialization, licensing, and development of safe, effective non-prescription medicine and consumer care products to improve men's and women's health and vitality as well as treat respiratory diseases. Innovus Pharma delivers innovative and uniquely-presented health solutions through its (a) OTC medicines and consumer/health products, which we market directly, (b) commercial partners to primary care physicians, urologists, gynecologists and therapists, and (c) directly to consumers through our online channels, retailers and wholesalers. The company is a leader in developing and marketing new OTC and branded Abbreviated New Drug Application ("ANDA") products while actively pursuing opportunities where existing prescription drugs have recently, or are expected to, change from prescription (or Rx) to OTC.